Filing Details
- Accession Number:
- 0001493152-23-000255
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-04 11:09:06
- Reporting Period:
- 2022-12-30
- Accepted Time:
- 2023-01-04 11:09:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1335105 | Lixte Biotechnology Holdings Inc. | LIXT | Pharmaceutical Preparations (2834) | 202903526 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1938070 | Jeroen Bastiaan Baan Der Van | Hogeweg 4-H Amsterdam P7 1098CP | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-30 | 10,000 | $4.90 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
